{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:53:10Z","timestamp":1794009190032,"version":"4.8.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81671113"],"award-info":[{"award-number":["81671113"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Natural Science Foundation of Jiangsu Province","award":["BK20231120"],"award-info":[{"award-number":["BK20231120"]}]},{"name":"Nanjing Medical Science and Technology Development Foundation","award":["ZKX22025"],"award-info":[{"award-number":["ZKX22025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) syndrome is a maternally inherited mitochondrial disorder that mostly affects the central nervous system and skeletal muscle. This study provides a comprehensive summary of the clinical symptoms, multisystemic pathogenesis, and genetic characteristics of MELAS syndrome. The aim was to improve comprehension of clinical practice and gain a deeper understanding of the latest pathophysiological theories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The present investigation involved a cohort of patients diagnosed with MELAS at Nanjing Drum Tower Hospital between January 2014 and December 2022. Multisystem symptoms, magnetic resonance imaging\/spectroscopy (MRI\/MRS), muscle biopsy, and mitochondrial DNA (mtDNA) data were summarized and subsequently analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This retrospective study included a cohort of 29 MELAS patients who predominantly presented symptoms such as stroke-like episodes, proximal muscle weakness, and exercise intolerance. MRI scans revealed very small infarcts beneath the deep cortex during stroke-like episodes, indicating nonvascular brain damage. Pathology analyses of the brain also showed neuronal degeneration and glial cell proliferation in the cerebral parenchyma. Proton magnetic resonance spectroscopy (\n                      <jats:sup>1<\/jats:sup>\n                      H-MRS) analysis revealed an increase in the lactate peak and a reduction in the N-acetylaspartate (NAA) level. Similarly, the phosphorus magnetic resonance spectroscopy (\n                      <jats:sup>31<\/jats:sup>\n                      P-MRS) analysis revealed an abnormal ratio of inorganic phosphate (Pi) to phosphocreatine (PCr). Muscle biopsy revealed the presence of ragged red fibres (RRFs) and cytochrome c oxidase (COX) enzyme-defective cells. These abnormalities indicate structural abnormalities in the mitochondria and deficiencies in oxidative phosphorylation, respectively. In addition to the common m.3243A\u2009&gt;\u2009G variant, other prevalent variants, including m.5628\u00a0T\u2009&gt;\u2009C, m.6352-13952del, and a 9-bp small deletion combined with m.3243A\u2009&gt;\u2009G, exist.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MELAS is a rare mitochondrial syndrome characterized by clinical heterogeneity and genetic heteroplasmy. Abnormalities in mitochondrial metabolic function and impairments in enzyme activity are the pathogenic processes underlying MELAS. Mitochondrial vasculopathy and mitochondrial neuropathy may provide a partial explanation for the unique aetiology of stroke-like episodes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-024-03511-4","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T05:21:59Z","timestamp":1735017719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Multisystem clinicopathologic and genetic analysis of MELAS"],"prefix":"10.1186","volume":"19","author":[{"given":"Shuai","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialiu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4696-9696","authenticated-orcid":false,"given":"Xiaolei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3845-0002","authenticated-orcid":false,"given":"Fengnan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,24]]},"reference":[{"key":"3511_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41439-018-0026-6","volume":"5","author":"T Ikeda","year":"2018","unstructured":"Ikeda T, Osaka H, Shimbo H, Tajika M, Yamazaki M, Ueda A, et al. Mitochondrial DNA 3243A>T mutation in a patient with MELAS syndrome. Hum Genome Var. 2018;5:25. https:\/\/doi.org\/10.1038\/s41439-018-0026-6.","journal-title":"Hum Genome Var"},{"key":"3511_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1530\/eje-20-0189","volume":"183","author":"HW Chae","year":"2020","unstructured":"Chae HW, Na JH, Kim HS, Lee YM. Mitochondrial diabetes and mitochondrial DNA mutation load in MELAS syndrome. Eur J Endocrinol. 2020;183:505\u201312. https:\/\/doi.org\/10.1530\/eje-20-0189.","journal-title":"Eur J Endocrinol"},{"key":"3511_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ymgme.2015.06.004","volume":"116","author":"AW El-Hattab","year":"2015","unstructured":"El-Hattab AW, Adesina AM, Jones J, Scaglia F. MELAS syndrome: clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab. 2015;116:4\u201312. https:\/\/doi.org\/10.1016\/j.ymgme.2015.06.004.","journal-title":"Mol Genet Metab"},{"key":"3511_CR4","doi-asserted-by":"publisher","first-page":"456","DOI":"10.5414\/cn107063","volume":"80","author":"A Seidowsky","year":"2013","unstructured":"Seidowsky A, Hoffmann M, Glowacki F, Dhaenens CM, Devaux JP, de Sainte Foy CL, et al. Renal involvement in MELAS syndrome - a series of 5 cases and review of the literature. Clin Nephrol. 2013;80:456\u201363. https:\/\/doi.org\/10.5414\/cn107063.","journal-title":"Clin Nephrol"},{"key":"3511_CR5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.mito.2008.05.003","volume":"8","author":"RP Saneto","year":"2008","unstructured":"Saneto RP, Friedman SD, Shaw DW. Neuroimaging of mitochondrial disease. Mitochondrion. 2008;8:396\u2013413. https:\/\/doi.org\/10.1016\/j.mito.2008.05.003.","journal-title":"Mitochondrion"},{"key":"3511_CR6","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/cns.12257","volume":"20","author":"AH Liu","year":"2014","unstructured":"Liu AH, Niu FN, Chang LL, Zhang B, Liu Z, Chen JY, et al. High cytochrome c oxidase expression links to severe skeletal energy failure by (31)P-MRS spectroscopy in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes. CNS Neurosci Ther. 2014;20:509\u201314. https:\/\/doi.org\/10.1111\/cns.12257.","journal-title":"CNS Neurosci Ther"},{"key":"3511_CR7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.bbagen.2011.03.015","volume":"1820","author":"S Yatsuga","year":"2012","unstructured":"Yatsuga S, Povalko N, Nishioka J, Katayama K, Kakimoto N, Matsuishi T, et al. MELAS: a nationwide prospective cohort study of 96 patients in Japan. Biochim Biophys Acta. 2012;1820:619\u201324. https:\/\/doi.org\/10.1016\/j.bbagen.2011.03.015.","journal-title":"Biochim Biophys Acta"},{"key":"3511_CR8","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1212\/01.wnl.0000244435.27645.54","volume":"67","author":"E Morava","year":"2006","unstructured":"Morava E, van den Heuvel L, Hol F, de Vries MC, Hogeveen M, Rodenburg RJ, et al. Mitochondrial disease criteria: diagnostic applications in children. Neurology. 2006;67:1823\u20136. https:\/\/doi.org\/10.1212\/01.wnl.0000244435.27645.54.","journal-title":"Neurology"},{"key":"3511_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10540-007-9046-z","volume":"27","author":"MC Bianchi","year":"2007","unstructured":"Bianchi MC, Sgandurra G, Tosetti M, Battini R, Cioni G. Brain magnetic resonance in the diagnostic evaluation of mitochondrial encephalopathies. Biosci Rep. 2007;27:69\u201385. https:\/\/doi.org\/10.1007\/s10540-007-9046-z.","journal-title":"Biosci Rep"},{"key":"3511_CR10","doi-asserted-by":"publisher","first-page":"116499","DOI":"10.1016\/j.jns.2019.116499","volume":"408","author":"Y Lu","year":"2020","unstructured":"Lu Y, Deng J, Zhao Y, Zhang Z, Hong D, Yao S, et al. Patients with MELAS with negative myopathology for characteristic ragged-red fibers. J Neurol Sci. 2020;408:116499. https:\/\/doi.org\/10.1016\/j.jns.2019.116499.","journal-title":"J Neurol Sci"},{"key":"3511_CR11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/s0014-4886(02)00012-2","volume":"179","author":"A Oliveira","year":"2003","unstructured":"Oliveira A, Hodges H, Rezaie P. Excitotoxic lesioning of the rat basal forebrain with S-AMPA: consequent mineralization and associated glial response. Exp Neurol. 2003;179:127\u201338. https:\/\/doi.org\/10.1016\/s0014-4886(02)00012-2.","journal-title":"Exp Neurol"},{"key":"3511_CR12","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1007\/s11011-021-00772-x","volume":"36","author":"S Tetsuka","year":"2021","unstructured":"Tetsuka S, Ogawa T, Hashimoto R, Kato H. Clinical features, pathogenesis, and management of stroke-like episodes due to MELAS. Metab Brain Dis. 2021;36:2181\u201393. https:\/\/doi.org\/10.1007\/s11011-021-00772-x.","journal-title":"Metab Brain Dis"},{"key":"3511_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1196\/annals.1444.011","volume":"1142","author":"DM Sproule","year":"2008","unstructured":"Sproule DM, Kaufmann P. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann NY Acad Sci. 2008;1142:133\u201358. https:\/\/doi.org\/10.1196\/annals.1444.011.","journal-title":"Ann NY Acad Sci"},{"key":"3511_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/088307389400900102","volume":"9","author":"M Hirano","year":"1994","unstructured":"Hirano M, Pavlakis SG. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J Child Neurol. 1994;9:4\u201313. https:\/\/doi.org\/10.1177\/088307389400900102.","journal-title":"J Child Neurol"},{"key":"3511_CR15","doi-asserted-by":"publisher","first-page":"e11839","DOI":"10.7759\/cureus.11839","volume":"12","author":"I Jameel","year":"2020","unstructured":"Jameel I, Sreh A, Das P. Recurrent stroke events secondary to a late presentation of mitochondrial encephalomyopathy with lactic acidosis and stroke-like symptoms (MELAS) syndrome. Cureus. 2020;12:e11839. https:\/\/doi.org\/10.7759\/cureus.11839.","journal-title":"Cureus"},{"key":"3511_CR16","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/s0242-6498(05)80132-4","volume":"25","author":"J Mikol","year":"2005","unstructured":"Mikol J, Polivka M. Mitochondrial encephalomyopathies. Ann Pathol. 2005;25:282\u201391. https:\/\/doi.org\/10.1016\/s0242-6498(05)80132-4.","journal-title":"Ann Pathol"},{"key":"3511_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1600-0404.1996.tb07058.x","volume":"94","author":"A Melberg","year":"1996","unstructured":"Melberg A, Akerlund P, Raininko R, Silander HC, Wibom R, Khaled A, et al. Monozygotic twins with MELAS-like syndrome lacking ragged red fibers and lactacidaemia. Acta Neurol Scand. 1996;94:233\u201341. https:\/\/doi.org\/10.1111\/j.1600-0404.1996.tb07058.x.","journal-title":"Acta Neurol Scand"},{"key":"3511_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10540-007-9034-3","volume":"27","author":"M Filosto","year":"2007","unstructured":"Filosto M, Tomelleri G, Tonin P, Scarpelli M, Vattemi G, Rizzuto N, et al. Neuropathology of mitochondrial diseases. Biosci Rep. 2007;27:23\u201330. https:\/\/doi.org\/10.1007\/s10540-007-9034-3.","journal-title":"Biosci Rep"},{"key":"3511_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/bf00688107","volume":"76","author":"B Lach","year":"1988","unstructured":"Lach B, Preston D, Embree G. Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol. 1988;76:216. https:\/\/doi.org\/10.1007\/bf00688107.","journal-title":"Acta Neuropathol"},{"key":"3511_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0022-510x(88)90005-6","volume":"86","author":"M Kishi","year":"1988","unstructured":"Kishi M, Yamamura Y, Kurihara T, Fukuhara N, Tsuruta K, Matsukura S, et al. An autopsy case of mitochondrial encephalomyopathy: biochemical and electron microscopic studies of the brain. J Neurol Sci. 1988;86:31\u201340. https:\/\/doi.org\/10.1016\/0022-510x(88)90005-6.","journal-title":"J Neurol Sci"},{"key":"3511_CR21","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1161\/01.str.25.9.1873","volume":"25","author":"TI Gropen","year":"1994","unstructured":"Gropen TI, Prohovnik I, Tatemichi TK, Hirano M. Cerebral hyperemia in MELAS. Stroke. 1994;25:1873\u20136. https:\/\/doi.org\/10.1161\/01.str.25.9.1873.","journal-title":"Stroke"},{"key":"3511_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/NRL.0b013e318247bcd8","volume":"18","author":"BP Walcott","year":"2012","unstructured":"Walcott BP, Edlow BL, Xia Z, Kahle KT, Nahed BV, Schmahmann JD. Steroid responsive A3243G mutation MELAS: clinical and radiographic evidence for regional hyperperfusion leading to neuronal loss. Neurologist. 2012;18:159\u201370. https:\/\/doi.org\/10.1097\/NRL.0b013e318247bcd8.","journal-title":"Neurologist"},{"key":"3511_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jocn.2018.06.015","volume":"55","author":"X Li","year":"2018","unstructured":"Li X, Wang Y, Wang Z, Lu J, Xu Y, Ye J, et al. Comparison of magnetic resonance spectroscopy (MRS) with arterial spin labeling (ASL) in the differentiation between mitochondrial encephalomyopathy, lactic Acidosis, plus stroke-like episodes (MELAS) and acute ischemic stroke (AIS). J Clin Neurosci. 2018;55:65\u201370. https:\/\/doi.org\/10.1016\/j.jocn.2018.06.015.","journal-title":"J Clin Neurosci"},{"key":"3511_CR24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/s0140-6736(99)05226-5","volume":"355","author":"JV Leonard","year":"2000","unstructured":"Leonard JV, Schapira AH. Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects. Lancet. 2000;355:389\u201394. https:\/\/doi.org\/10.1016\/s0140-6736(99)05226-5.","journal-title":"Lancet"},{"key":"3511_CR25","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/cns.12714","volume":"23","author":"FN Niu","year":"2017","unstructured":"Niu FN, Meng HL, Chang LL, Wu HY, Li WP, Liu RY, et al. Mitochondrial dysfunction and cerebral metabolic abnormalities in patients with mitochondrial encephalomyopathy subtypes: Evidence from proton MR spectroscopy and muscle biopsy. CNS Neurosci Ther. 2017;23:686\u201397. https:\/\/doi.org\/10.1111\/cns.12714.","journal-title":"CNS Neurosci Ther"},{"key":"3511_CR26","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.euroneuro.2014.06.004","volume":"24","author":"G Paslakis","year":"2014","unstructured":"Paslakis G, Tr\u00e4ber F, Roberz J, Block W, Jessen F. N-acetyl-aspartate (NAA) as a correlate of pharmacological treatment in psychiatric disorders: a systematic review. Eur Neuropsychopharmacol. 2014;24:1659\u201375. https:\/\/doi.org\/10.1016\/j.euroneuro.2014.06.004.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3511_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1055\/s-2007-973767","volume":"27","author":"L Valanne","year":"1996","unstructured":"Valanne L, Paetau A, Suomalainen A, Ketonen L, Pihko H. Laminar cortical necrosis in MELAS syndrome: MR and neuropathological observations. Neuropediatrics. 1996;27:154\u201360. https:\/\/doi.org\/10.1055\/s-2007-973767.","journal-title":"Neuropediatrics"},{"key":"3511_CR28","doi-asserted-by":"publisher","first-page":"e00325","DOI":"10.1016\/j.neurot.2024.e00325","volume":"21","author":"BJ Shayota","year":"2024","unstructured":"Shayota BJ. Biomarkers of mitochondrial disorders. Neurotherapeutics. 2024;21:e00325. https:\/\/doi.org\/10.1016\/j.neurot.2024.e00325.","journal-title":"Neurotherapeutics"},{"key":"3511_CR29","doi-asserted-by":"publisher","first-page":"7115","DOI":"10.1038\/s41467-021-27426-x","volume":"12","author":"C Adam","year":"2021","unstructured":"Adam C, Paolini L, Gueguen N, Mabilleau G, Preisser L, Blanchard S, et al. Acetoacetate protects macrophages from lactic acidosis-induced mitochondrial dysfunction by metabolic reprograming. Nat Commun. 2021;12:7115. https:\/\/doi.org\/10.1038\/s41467-021-27426-x.","journal-title":"Nat Commun"},{"key":"3511_CR30","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/dme.13874","volume":"36","author":"X Geng","year":"2019","unstructured":"Geng X, Zhang Y, Yan J, Chu C, Gao F, Jiang Z, et al. Mitochondrial DNA mutation m.3243A>G is associated with altered mitochondrial function in peripheral blood mononuclear cells, with heteroplasmy levels and with clinical phenotypes. Diabet Med. 2019;36:776\u201383. https:\/\/doi.org\/10.1111\/dme.13874.","journal-title":"Diabet Med"},{"key":"3511_CR31","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.4103\/0366-6999.159360","volume":"128","author":"YX Wang","year":"2015","unstructured":"Wang YX, Le WD. Progress in diagnosing mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Chin Med J (Engl). 2015;128:1820\u20135. https:\/\/doi.org\/10.4103\/0366-6999.159360.","journal-title":"Chin Med J (Engl)"},{"key":"3511_CR32","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/s0960-8966(01)00195-x","volume":"11","author":"M Spagnolo","year":"2001","unstructured":"Spagnolo M, Tomelleri G, Vattemi G, Filosto M, Rizzuto N, Tonin P. A new mutation in the mitochondrial tRNA(Ala) gene in a patient with ophthalmoplegia and dysphagia. Neuromuscul Disord. 2001;11:481\u20134. https:\/\/doi.org\/10.1016\/s0960-8966(01)00195-x.","journal-title":"Neuromuscul Disord"},{"key":"3511_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.nmd.2009.10.010","volume":"20","author":"CL Alston","year":"2010","unstructured":"Alston CL, Morak M, Reid C, Hargreaves IP, Pope SA, Land JM, et al. A novel mitochondrial MTND5 frameshift mutation causing isolated complex I deficiency, renal failure and myopathy. Neuromuscul Disord. 2010;20:131\u20135. https:\/\/doi.org\/10.1016\/j.nmd.2009.10.010.","journal-title":"Neuromuscul Disord"},{"key":"3511_CR34","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/acn3.51787","volume":"10","author":"W Wang","year":"2023","unstructured":"Wang W, Zhao Y, Xu X, Ma X, Sun Y, Lin Y, et al. A different pattern of clinical, muscle pathology and brain MRI findings in MELAS with mt-ND variants. Ann Clin Transl Neurol. 2023;10:1035\u201345. https:\/\/doi.org\/10.1002\/acn3.51787.","journal-title":"Ann Clin Transl Neurol"},{"key":"3511_CR35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1196\/annals.1338.058","volume":"1042","author":"CS Liu","year":"2005","unstructured":"Liu CS, Cheng WL, Chen YY, Ma YS, Pang CY, Wei YH. High prevalence of the COII\/tRNA(Lys) intergenic 9-bp deletion in mitochondrial DNA of Taiwanese patients with MELAS or MERRF syndrome. Ann NY Acad Sci. 2005;1042:82\u20137. https:\/\/doi.org\/10.1196\/annals.1338.058.","journal-title":"Ann NY Acad Sci"},{"key":"3511_CR36","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.sjbs.2014.11.001","volume":"22","author":"IA Khan","year":"2015","unstructured":"Khan IA, Shaik NA, Pasupuleti N, Chava S, Jahan P, Hasan Q, et al. Screening of mitochondrial mutations and insertion-deletion polymorphism in gestational diabetes mellitus in the Asian Indian population. Saudi J Biol Sci. 2015;22:243\u20138. https:\/\/doi.org\/10.1016\/j.sjbs.2014.11.001.","journal-title":"Saudi J Biol Sci"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03511-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03511-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03511-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T06:04:19Z","timestamp":1735020259000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03511-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3511"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03511-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,24]]},"assertion":[{"value":"2 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed Chinese legal regulations and this study was approved by the Medical Ethics Committee of the Affiliated Drum Tower Hospital of Nanjing University Medicine School, under approval number 2020-349-03. All participants provided written informed consent and the procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"487"}}